In addition, the results of a meta-analysis [33] also showed that carriers of one or both GPX1-Leu alleles had an approximately 2-fold higher risk of developing bladder cancer, compared to GPX1 Pro/Pro genotype. The gene discussed is GPX1; the disease is urinary bladder carcinoma.